" /> Ivosidenib - CISMeF





Preferred Label : Ivosidenib;

NCIt definition : An orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Upon administration, AG-120 specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhibits the formation of the oncometabolite, 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH1-expressing tumor cells. IDH1, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.;

UNII : Q2PCN8MAM6;

InChIKey : WIJZXSAJMHAVGX-DHLKQENFSA-N;

CAS number : 1448347-49-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1448347-49-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Tibsovo;

Molecule name : AG-120;

NCI Metathesaurus CUI : CL471818;

Codes from synonyms : 287;

Details


You can consult :


Nous contacter.
02/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.